MYC‐driven malignant transformation of mature murine B cells requires inhibition of both intrinsic apoptosis and p53 activity
Authors:
- 12 October 2018
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 49 (3) , 375-385
Abstract
Increased expression of the oncogene MYC is a common feature of many B‐cell malignancies, however MYC overexpression by itself is not sufficient for transformation, and additional genetic events are required, although the exact nature of these remains unknown. In patients and in transgenic mouse models, oncogenic transformation may occur in B cells at various differentiation stages interacting with complex microenvironments. B‐cell oncogenesis often occurs after prolonged periods of time, making it difficult to accurately identify the genetic events required for transformation. An in vitro system, where malignant transformation of primary B cells could be analyzed, would facilitate the identification of genetic events required for transformation. Here, we describe such a system and show that primary murine B cells rapidly become transformed upon forced expression of MYC, in conjunction with simultaneous inhibition of the ARF/p53 axis via overexpression of BMI1, as well as through downregulation of p19ARF or expression of a dominant‐negative p53 and suppression of intrinsic apoptosis through overexpression of BCLXL or MCL1. Established tumor cells remained addicted to expression of the lymphoma‐inducing genes. In mice, transformed cells rapidly established fatal B‐cell lymphomas.Our results suggest that transformation of normal mature B cells into lymphomas can occur as a consequence of three defined events.Keywords
Funding Information
- Vetenskapsrådet
- Cancerfonden
This publication has 41 references indexed in Scilit:
- Inhibition of the Intrinsic but Not the Extrinsic Apoptosis Pathway Accelerates and Drives Myc-Driven Tumorigenesis Towards Acute Myeloid LeukemiaPLOS ONE, 2012
- Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in miceBlood, 2011
- Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistanceBlood, 2010
- The Ink4/Arf locus is a barrier for iPS cell reprogrammingNature, 2009
- Participation of FLIP, RIP and Bcl-xLin Fas-mediated T-cell DeathScandinavian Journal of Immunology, 2007
- Analysis of apoptosis by propidium iodide staining and flow cytometryNature Protocols, 2006
- A Network of Genetic Events Sufficient to Convert Normal Human Cells to a Tumorigenic StateCancer Research, 2005
- B‐cell homeostasis, competition, resources, and positive selection by self‐antigensImmunological Reviews, 2004
- The SCID but Not the RAG-2 Gene Product Is Required for Sμ–Sε Heavy Chain Class SwitchingImmunity, 1996
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985